Health Condition 1: C50- Malignant neoplasm of breast
Conditions
Interventions
Intervention1: SERS-Nanoprobes/ SERS Chip platforms: 2) Multiplex, SERS-based immuno-assay, SERS- nanotags as target biomarker against antibody labelled and SERS chips, as label-free detection platfor
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: Male or female with histopathological proven diagnosis of breast carcinoma.
Exclusion criteria
Exclusion criteria: NA
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| . OBJECTIVES: 1) Develop nanobiosensor platforms and associated technologies for easy differential screening and detection of breast (ER, PR, HER-2 & Ki67) biomarkers 2) Multiplex, SERS-based immuno-assay, SERS- nanotags as target biomarker against antibody labelled and SERS chips, as label-free detection platform for sensitive and specific detection of the predictive markers in tumor tissue (micro-environment) Timepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Develop nanobiosensor platforms and associated technologies for easy differential screening and detection of breast (ER, PR, HER-2 & Ki67) biomarkers 2) Multiplex, SERS-based immuno-assay, SERS- nanotags as target biomarker against antibody labelled and SERS chips, as label-free detection platform for sensitive and specific detection of the predictive markers in tumor tissue (micro-environment) Timepoint: Baseline | — |
Countries
India
Contacts
Public ContactYogesh Kembhavi
Tata Memorial Centre
Outcome results
None listed